Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans

Cyrill Schipp, Schafiq Nabhani, Kirsten Bienemann, Natalia Simanovsky, Shlomit Kfir-Erenfeld, Nathalie Assayag-Asherie, Prasad T. Oommen, Shoshana Revel-Vilk, Andrea Hönscheid, Michael Gombert, Sebastian Ginzel, Daniel Schäfer, Hans Jürgen Laws, Eitan Yefenof, Bernhard Fleckenstein, Arndt Borkhardt, Polina Stepensky, Ute Fischer*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

38 Scopus citations
Original languageEnglish
Pages (from-to)e392-e396
JournalHaematologica
Volume101
Issue number10
DOIs
StatePublished - 30 Sep 2016

Keywords

  • Antibody deficiency
  • Autoimmune lymphoproliferative syndrome
  • Autoinflammatory disease
  • Fas
  • Immunodeficiency
  • NFKB

Cite this